Home | UCSF Helen Diller Family Comprehensive Cancer Center

Novel Immunotherapy Combination Destroys Colorectal Liver Metastases

Researchers from UC San Francisco, have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver.

How AI is Changing Brain Tumor Surgery

High-tech imaging approaches allow neurosurgeons to interpret tissue samples during surgery to remove previously invisible malignant cells.

UCSF Helen Diller Family Cancer Research Building

UCSF Awarded $12M Research Grant to Improve Cancer Outcomes

SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.

How 100,000 Grandmas Fight Cancer in Every Human Cell

From curing Alzheimer’s to preventing cancer and pneumonia, UCSF postdoctoral scholars tackle complex medical conditions at annual Postdoc Slam competition.

Danger: Pesticides Raise Death Risk 60% for Kids with Leukemia

UCSF-led study examined more than 800 children with acute lymphoblastic leukemia (ALL), looking at how pesticide exposure affected five-year survival rates.

Repurposing a Diabetes Medication to Prime CAR T Cancer Targets

The first FDA-approved antibody-drug conjugate therapy for metastatic UC (mUC), enfortumab vedotin (EV), targets NECTIN4, a protein that is expressed on the cell surface of bladder cancer cells, and is now the frontline, standard of care treatment for patients with advanced urothelial carcinoma in the U.S.